These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 8703620)

  • 21. [The importance of cytokines in the posttraumatic inflammatory reaction].
    Hildebrand F; Pape HC; Krettek C
    Unfallchirurg; 2005 Oct; 108(10):793-4, 796-803. PubMed ID: 16175346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased production of inflammatory cytokines in mild cognitive impairment.
    Magaki S; Mueller C; Dickson C; Kirsch W
    Exp Gerontol; 2007 Mar; 42(3):233-40. PubMed ID: 17085001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytokines and severe infections].
    Offenstadt G; Guidet B; Staikowsky F
    Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):820-31. PubMed ID: 8309725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines.
    Barak V; Schwartz A; Kalickman I; Nisman B; Gurman G; Shoenfeld Y
    Am J Med; 1998 Jan; 104(1):40-7. PubMed ID: 9528718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathophysiological role of cytokines in congestive heart failure.
    Blum A; Miller H
    Annu Rev Med; 2001; 52():15-27. PubMed ID: 11160765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine modifiers: pipe dream or reality?
    Abraham E
    Chest; 1998 Mar; 113(3 Suppl):224S-227S. PubMed ID: 9515897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for blocking the systemic effects of cytokines in the sepsis syndrome.
    Christman JW; Holden EP; Blackwell TS
    Crit Care Med; 1995 May; 23(5):955-63. PubMed ID: 7736757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model.
    Hildebrand F; Pape HC; Hoevel P; Krettek C; van Griensven M
    Shock; 2003 Oct; 20(4):338-46. PubMed ID: 14501948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis.
    Novotny AR; Reim D; Assfalg V; Altmayr F; Friess HM; Emmanuel K; Holzmann B
    Immunobiology; 2012 Jun; 217(6):616-21. PubMed ID: 22204813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infections and the inflammatory response in acute respiratory distress syndrome.
    Headley AS; Tolley E; Meduri GU
    Chest; 1997 May; 111(5):1306-21. PubMed ID: 9149588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
    Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
    Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor.
    Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N
    J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytokines as biomarkers of the patients state severity and prognostication in burns: new therapeutic possibilities of existing approaches in treatment. Part 2].
    Kovalenko OM; Mal'tsev DB; Kazmirchuk VIe; Kozynets HP
    Klin Khir; 2012 Jan; (1):57-61. PubMed ID: 22642092
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies.
    Hu DE; Hori Y; Presta M; Gresham GA; Fan TP
    Inflammation; 1994 Feb; 18(1):45-58. PubMed ID: 7515856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated interleukin-1 receptor antagonist levels in pediatric sepsis syndrome.
    Samson LM; Allen UD; Creery WD; Diaz-Mitoma F; Singh RN
    J Pediatr; 1997 Oct; 131(4):587-91. PubMed ID: 9386664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine neutralizing strategies in experimental sepsis.
    Enayati P; Fong Y
    Prog Clin Biol Res; 1994; 388():295-306. PubMed ID: 7831365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.